Vaccinogen, Inc.

Vaccinogen, Inc. (Vaccinogen) is a privately held bio-pharmaceutical company engaged in the development and commercialization of cancer vaccines and other immunotherapeutic products. The company offers OncoVAX, which is the only immunotherapy for Stage II colon cancer. Its products are used in the treatment of cancer, infectious disease, autoimmune and anti-inflammatory diseases. Vaccinogen is also involved in the discovery, development and manufacture of fully human monoclonal antibodies for human clinical use. In addition, the company develops immunotherapy products to treat solid tumors and commercializes autologous tumor vaccine products. It has 20 issued US patents; and follow-on products based on pivotal study in colon carcinoma and phase I/II data in stage III colon carcinoma, renal carcinoma and melanoma. The company is headquartered at Frederick in Maryland, the US.

Street: 
5300 Westview Drive
City: 
Frederick
Postcode: 
21703
Federal State : 
United States
WebSite: 
www.vaccinogeninc.com

Company Index Score

Current Index Score Historical Index Score
  • Vaccinogen, Inc. currently scores 50 % in the index.
  • Vaccinogen, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Vaccinogen, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets